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Background: Few studies have examined the differential effects of weight management by exercise mode on
subclinical atherosclerosis. We hypothesized that 3 modes of aerobic, resistance, and combination exercises have
differential effects on the flow-mediated dilation (FMD), carotid-femoral pulse wave velocity (PWV), and carotid
intima-media thickness (IMT) as well as cardiometabolic profile in weight management.
Methods: A randomized, single-blind trial (ISRCTN46069848) was conducted in Seoul, South Korea between
November 2011 and December 2012. Randomized participants were 110 women with abdominal obesity (aerobic
group n = 50; resistance group n = 30; combination exercise group n = 30). The treatment period was 12 months
with 3-month follow up: A diet-alone intervention for the first 3 months and a diet-plus-exercise intervention for
the next 9 months according to exercise modes. The exercise training was designed with an intensity of 50-70% heart
rate reserve for 3 days a week in 60-minute-long sessions for 9 months, consisting of 30-minute treadmill and 30-minute
bike exercises for aerobic group; upper and lower body exercises with an intensity target of 2 sets and 8–12 repetitions
for resistance group; 30-minute resistance and consecutive 30-minute aerobic exercises for combination group.
Results: Ninety-two and 49 participants were analyzed for modified intention-to-treat analysis and per-protocol
(PP) analysis, respectively. The 3 exercise modes had no significant differential effects on FMD, PWV, and IMT over
time; however, the combination group was found to have significantly lower levels of fasting glucose than the
aerobic group (p = .034) in the PP analysis. Nevertheless, we observed significant time effects such as reductions
in PWV (p = .048) and IMT (p = .018) in cubic and quadratic trends, respectively, and improvements in body weight,
waist circumference, low-density and high-density lipoprotein cholesterol levels, fasting glucose levels, and
cardiorespiratory fitness in linear, quadratic, or cubic trends.
Conclusions: For women with abdominal obesity, a combination of aerobic and resistance exercises may be
preferable to a single exercise mode for effective glucose control. Regardless of exercise mode, exercise
interventions combined with dietary interventions in weight management may be beneficial in reducing the risk
of subclinical atherosclerosis and cardiometabolic risk.Background
Abdominal obesity is a risk factor for coronary heart
disease (CHD). Prospective cohort studies have reported
that an increase in waist circumference is significantly
associated with CHD incidence and mortality [1]. In
addition, abdominal obesity was found to be associated* Correspondence: jinachoo@gmail.com
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unless otherwise stated.with subclinical atherosclerotic risk, as assessed by endo-
thelial dysfunction [2], aortic stiffness [3], and carotid
atherosclerosis [3,4]. Particularly, the risk for CHD associ-
ated with increased waist circumference may be promin-
ent in women [1,5-7], and, in this context, the potential
for reducing CHD risk may also be significant in women.
Diet-plus-exercise interventions are commonly recom-
mended for enhancing long-term weight management
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have been found to have weaker effects than diet-plus-
exercise interventions on weight loss [10,11]. However,
exercise training may have beneficial effects on the
regression of subclinical atherosclerosis [12]. A few studies
have reported that either aerobic or resistance exercise
training improved endothelial dysfunction [13,14], aortic
stiffness [15,16], and carotid intima-media thickness
(IMT) [17]. However, their effects may differ by exercise
modes, i.e., aerobic, resistance, or combination exercise,
because each mode leads to different patterns of blood
flow and levels of pressure on the endothelium and arter-
ial wall [18,19]. Meanwhile, recent studies have reported
that a combination of aerobic and resistance exercises
may be more effective on improving anthropometric
and cardiometabolic profiles than aerobic or resistance
exercise alone [20,21]. In particular, combination exer-
cise was reported to be the most efficacious means of
decreasing body weight and waist circumference among
overweight and obese adults [20,22] and to have an
additional beneficial effect on glucose control compared
with either aerobic or resistance exercise for those
with type 2 diabetes mellitus [21]. However, there is
no information regarding whether the 3 exercise modes,
i.e., aerobic, resistance, and combination exercises, have
differential effects on markers of subclinical atheroscler-
osis such as endothelial function, aortic stiffness, or
carotid IMT as well as cardiometabolic profile among
overweight and obese individuals.
The purpose of the study was to test the hypothesis
that aerobic, resistance, and combination exercises in a
weight management intervention would have significant
differential effects on markers of subclinical atherosclerosis,
as measured by brachial flow-mediated dilation (FMD),
carotid-femoral pulse wave velocity (PWV) and mean IMT
levels at the common carotid artery, and cardiometabolic
profile among women with abdominal obesity in the
Community-based Heart and Weight Management Trial.
Methods
Study participants and enrollment procedure
We recruited the study subjects from a community (i.e.,
Seongbuk-Gu) in Seoul, South Korea. The community was
characterized as an urban county with a population size of
approximately 490,000 residents. Between November 2010
and November 2011, study participants were recruited via
poster, leaflet, telephone, and mass mailing advertisements
at the municipal health center, churches, universities, and
online communities. Eligible participants were invited to
an orientation where they were provided a detailed study
overview, asked for consent, and screened for additional
inclusion criteria. The inclusion criteria were as follows:
healthy women aged between 18 and 65 years, elevated
waist circumference (≥85 cm) according to the criteriafor abdominal obesity as defined by the Korean Society
for the Study of Obesity [23,24], and willingness to be
randomly assigned to one of the 3 different exercise
modes (i.e., aerobic, resistance, and combination exercise
training). The exclusion criteria included current medical
conditions such as cardiovascular diseases, diabetes, or
cancers; physical limitations restricting exercise ability;
current use of hormone therapy; history of participation
in a weight loss intervention in the last 1 year; and a
weight change in the last 4 weeks prior to participation in
our study. Before commencing with the randomization of
participants, baseline measurements of body composition
(body mass index [BMI] and waist circumference), blood
lipids, and fasting glucose were obtained; information
regarding sociodemographic and psychosocial variables
were obtained through questionnaires. The study was
approved by the Institutional Review Board at Korea
University (KU-IRB-11-10-A-2). All participants provided
written informed consent.
Study design
The Community-based Heart and Weight Management
Trial (trial registration no. ISRCTN46069848) includes a
randomized 12-month intervention with 3 different exer-
cise groups: aerobic training only, resistance training only,
and a combination of aerobic and resistance training. The
intervention assignment was carried out using a random
allocation computer program (n = 50 for aerobic exercise,
n = 30 for resistance exercise, and n = 30 for combination
exercise) (Figure 1). Initially, the aerobic exercise group
(n = 50) was further divided into 2 groups: one group
with (n = 30) and the other group without behavioral
therapy (n = 20). However, because there were no sig-
nificant differences in the outcome variables between
both the groups, we pooled the participants of those 2
groups into 1 aerobic exercise group (n = 50) for the
present study. This study was a single-blinded trial;
assessors of all the outcomes were blinded to participant
group assignment, and all outcome data were blinded
until the completion of final data entry for the 12-month
assessment.
Intervention
We conducted 2 consecutive types of interventions: diet-
alone vs. diet-plus-exercise interventions in a sequence
over a 12-month weight management program (Figure 2),
i.e., a diet-alone intervention for the first 3 months and
a diet-plus-exercise intervention for the next 9 months
according to exercise modes; for the diet-alone interven-
tion, the 3 groups were asked not to attend any exercise
training sessions for the first 3 months.
The exercise intervention over the following 9 months
was added to the diet-alone intervention: 60-minute exer-
cise sessions were conducted 3 times a week in a public
Figure 1 Participant flow chart.
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supervision of exercise trainers. The aerobic session
consisted of 30-minute treadmill exercise and 30-minute
bike exercise, with an intensity target of 50–70% of heart
rate reserve. The resistance session consisted of both
upper and lower body exercises: chest press, lat pull-
down, abdominal crunches, back extensions, leg curl, leg
extensions, leg press, and calf raise. The load was initially
set at 40% and 50% (or 60%) of maximum strength for the
upper extremities and lower extremities, respectively. Two
sets of 8–12 repetitions were performed during each
session. The rest period between each set was less than
90 seconds. The load was progressively increased by 5%
every 3 weeks or when subjects could easily perform 15
repetitions. Combination training consisted of 30 minutes
of resistance exercise and a consecutive 30-minute session
of aerobic exercise (15 minutes on a treadmill and
15 minutes on a bicycle) with 1 set of 8–12 repetitionsfor resistance exercise and 50–70% of the heart rate
reserve for aerobic exercise.
The diet-alone intervention was administered to all
participants, with individualized daily calorie intake
(1,200 kcal if the weight was <90.5 kg; 1,500 kcal if the
weight was ≥90.5 kg) and fat intake goals (≤25% of
total calories), taking into account their baseline body
weight measurements. Additionally, all the groups except
the aerobic group without behavioral therapy (n = 20)
received behavioral counseling (12 sessions of group
classes over 6 months) and were also taught the use of
established behavior change strategies including goal
setting and self-monitoring [25].
Measurements
The primary outcome of the trial was FMD. The second-
ary outcomes included improvements in other markers of
subclinical atherosclerosis (i.e., PWV and carotid IMT),
Figure 2 The 12-month weight management intervention in the present study. Following random allocation, a diet-alone intervention for
the first 3 months and a diet-plus-exercise intervention according to the exercise modes for the next 9 months were implemented over
12 months. The assessments were conducted at baseline, 3, 6, 9, and 12 months.
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mass), cardiometabolic profile (i.e., waist circumference,
systolic blood pressure, total cholesterol, low-density lipo-
protein [LDL] cholesterol, high-density lipoprotein [HDL]
cholesterol, triglycerides, and fasting glucose), and car-
diorespiratory fitness (i.e., maximal oxygen consumption
[VO2max]).
All measures were assessed at baseline, 3, 6, and
12 months. Weight was measured after an overnight fast,
using the Tanita bioelectrical impedance scale (Tanita
Corporation of America, Inc., IL, USA); prior to being
weighed, the participants were asked to wear light-
weight clothing and take off their shoes. Height was
measured using a wall-mounted stadiometer. The BMI was
computed as weight (kg)/height (m)2. Waist circumference
(cm) was measured twice using a Gullick II measuring
tape at the midpoint between the lowest rib and the
iliac crest; the average of 2 measurements was used.
Blood samples were drawn from the antecubital vein in
the morning after a 10-hour overnight fast without taking
any current medications, including anti-hypertensive or
lipid-lowering medications, when participants visited
the municipal health center. Participants who took anti-
hypertensive (n = 11) or lipid-lowering medications (n = 7)
were instructed to take them during the study period.
Samples were analyzed using a biochemical auto-analyzer
(Hitachi cobas c501; Hitachi, Japan) at the Department of
Clinical Laboratory of the municipal health center, in
Seoul, South Korea. Total cholesterol and HDL choles-
terol levels were measured by a homogeneous enzymatic
colorimetric test. The levels of triglycerides and glucosewere measured using the GPO-PAP method and the
hexokinase method, respectively. LDL cholesterol level
was estimated according to the Friedewald equation [26].
For non-invasive assessment of the FMD, brachial artery
dilatation was measured by ultrasonography (ACUSON X
300; Siemens, Mountain View, CA). The brachial artery
was imaged in longitudinal sections 5–10 cm proximal to
the placement of a blood pressure cuff, just below the
antecubital fossa, using a high frequency linear array
probe (11.4 MHz). The FMD was measured for 1 minute
at baseline and again for 2 minutes after an ischemic
stimulus (inflation of a blood pressure cuff around the
forearm to 200 mmHg for 5 minutes). The FMD was
analyzed using a semi-automated edge detection software
system (Brachial Analyzer 5; Medical Imaging Applications,
Coralville, IA) to calculate FMD (%) according to the
following equation: [(maximum diameter – baseline
diameter)/baseline diameter] × 100. A reproducibility (i.e.,
intraclass correlation coefficient) of 0.95 was achieved
within technicians.
Carotid to femoral PWV value was derived to measure
central arterial stiffness, using a SphygmoCor®system
(AtCor Medical, Sydney, Australia). The distance from
the carotid artery sample site to the femoral artery
and that from the carotid artery to the suprasternal
notch were measured as straight lines with a tape
measure. Pulse waves were obtained by applanation
tonometry. According to the “foot-to-foot” method, PWV
was determined as D/(Δt) (m/s), where Δt is the time
difference between carotid-femoral pressure waves, and
D is the distance between the 2 arteries. All measurements
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for subsequent analysis. Arterial stiffness was measured in
accordance with the guidelines of the Clinical Application
of Arterial Stiffness, Task Force III. A reproducibility (i.e.,
intraclass correlation coefficient) of 0.98 was achieved
within technicians.
Carotid artery ultrasound imaging was performed using
a high-resolution B-mode ultrasound system (ACUSON X
300; Siemens, Mountain View, CA). The IMT was defined
as the distance from the leading edge of the lumen-intima
interface to the leading edge of the media-adventitia inter-
face of the far wall of the carotid artery. All measurements
were made at the end diastole. The carotid IMT of the
common carotid artery was determined from a semi-
automated measurement obtained 2 cm proximal to the
carotid bifurcation. The value for carotid IMT was defined
as the mean of the IMT. A reproducibility (i.e., intra-
class correlation coefficient) of 0.99 was achieved within
technicians.
Cardiorespiratory fitness levels were reported as VO2max
values estimated using the Rockport Fitness Walking Test.
Participants were administered the 1-mile walk test on an
outdoor track in accordance with the protocol of Kline
et al. [27].
Statistical analysis
Sample size calculation was based on Olson et al.’s study
[13]. The study showed a decreased mean FMD change
of 1.4% (standard deviation [SD], 2.32%) at the 12-month
follow-up in the control group and an increased mean
FMD change of 2.6% (SD, 3.49%) in the resistance group.
We considered two-thirds of mean change difference
between groups as an effect size for our study because
all of our groups received a diet program. To detect a
mean difference in FMD of 2.67% by assuming the SD
from Olson et al., between any pairs of the 3 groups in
our study, at least 21 subjects per group were needed to
ensure an 80% power with the Student’s t-test and 2-tailed
test at the 5% level of significance. Considering the 30%
follow-up loss rate during the study period, we initially
planned to randomize a total of 90 subjects to 3 study
groups (30 participants per group). However, as mentioned
in the Study Design section, the actually allocated sample
sizes were 50 participants to aerobic, 30 participants
to resistance, and 30 participants to the combination
exercise group.
To test the homogeneity of exercise groups in terms of
baseline measures for sociodemographic, health-related,
subclinical atherosclerosis, anthropometric, cardiometa-
bolic, and cardiorespiratory fitness variables, one-way
ANOVA, X2 test, and Fisher's exact test were performed.
The modified intention-to-treat (ITT) population, defined
as randomized subjects with least 1 FMD measure re-
ported across 4 assessment periods, was used to analyzethe primary outcome variable. This population consisted
of 92 (84%) out of 110 randomized participants (Figure 1).
The main effects of exercise group and time as well as the
interaction effects between exercise group and time were
examined using a generalized estimating equation (GEE)
model for repeated measures over time. Covariates
adjusted for in the GEE model included baseline values
and marital status. Per-protocol (PP) analyses were also
conducted; the participants involved in this analysis were
defined as a subgroup of participants who met the criteria
of 100% follow-up by the fifth assessment over 12 months.
All analyses were performed using STATA 10.0 (Stata-
Corp LP., USA). A 2-tailed p-value of less than 0.05 was
considered statistically significant.
Results
The participants had a mean age of 43.1 years, mean
BMI of 28.5 kg/m2, and mean waist circumference of
94.8 cm (Table 1). Of all participants, 24.5% had an
obesity-related condition such as hypertension or dyslip-
idemia and 29.1% were post-menopausal. Some of the
baseline cardiometabolic profile (i.e., waist circumference
and total and HDL cholesterol levels) were outside the
reference ranges according to the criteria for abdominal
obesity in women as defined by the Korean Society for the
Study of Obesity [23], criteria of the National Cholesterol
Education Program (NCEP) Adult Treatment Panel III
(ATP III) [28], and diagnostic criteria for metabolic syn-
drome according to the NCEP-ATP III [29]. The mean
fitness level, as measured by VO2max, was 31.1 mL · kg
−1 ·
min−1. The participants in the resistance group were highly
likely to be married compared to those in the aerobic or
combination exercise groups (F = 6.57, p = .037).
Table 2 summarizes the results for differential effects
of exercise mode on outcome variables over time in
weight management, i.e., the interaction effects between
exercise groups and time on markers of subclinical ath-
erosclerosis and anthropometric and cardiometabolic
profiles on the basis of both modified ITT and PP ana-
lyses. We did not find significant interaction effects for
any of the outcome variables, except for fasting glucose
levels. The PP analyses revealed that changes in fasting
glucose levels significantly differed by the exercise mode
(p = .034); significant reductions in fasting glucose levels
were seen in the combination exercise group as compared
with that in the aerobic group. Specifically, an additional
analysis revealed that such a significant differential effect
occurred at 12 months (p = .004), and the changes in fast-
ing glucose levels in the combination exercise group
showed a liner trend (p = .014) (data not shown).
Table 3 summarizes the time effects for all the 3
groups on the outcome variables, based on the results of
modified ITT and PP analyses. We found significant time
effects for PWV (p = .048) and IMT (p = .018). We also
Table 1 Participants’ characteristics (N = 110)
n (%) or mean (SD)
F/χ2/
Fisher's P
*
Total
(n = 110)
Aerobic
(n = 50)
Resistance
(n = 30)
Combination
(n = 30)
Sociodemographic characteristics
Age, years 43.1 (9.0) 42.2 (9.5) 46.0 (10.0) 41.8 (6.6) 2.16 .120
Married, yes 90 (81.8) 37 (74.0) 29 (97.6) 24 (80.0) 6.57 .037
Education 0.78 .678
Some college or more 66 (60.0) 31 (62.0) 16 (53.3) 19 (63.3)
High school degree or less 44 (40.0) 19 (38.0) 14 (46.7) 11 (36.7)
Monthly household income ($) 1.37 .503
<=3,500 61 (55.5) 30 (60.0) 14 (46.7) 17 (56.7)
> 3,500 49 (44.5) 20 (40.0) 16 (53.3) 13 (43.3)
Employed, yes 43 (39.1) 19 (38.0) 11 (36.7) 13 (43.3) 0.33 .850
Health-related characteristics
Obesity-related conditions, yes 27 (24.5) 15 (30.0) 8 (26.7) 4 (13.3) 2.91 .233
Post-menopause, yes 32 (29.1) 15 (30.0) 12 (40.0) 5 (16.7) 4.00 .136
Current smoking, yes 6 (5.5) 2 (4.0) 1 (3.3) 3 (10.0) 1.57 .556
Alcohol drinking (twice or more/week), yes 9 (8.2) 4 (8.0) 2 (6.7) 3 (10.0) 0.36 1.000
Anti-hypertensive medication, yes 11 (10.0) 7 (14.0) 4 (13.3) 0 (0.0) 5.22 .101
Lipid-lowering medication, yes 7 (6.4) 0 (0.0) 5 (16.7) 2 (6.7) 8.74 .007
Markers of subclinical atherosclerosis
FMD, % 10.76 (3.457) 11.10 (3.263) 9.94 (3.477) 11.08 (3.723) 1.18 .310
PWV, m/sec 7.86 (1.356) 7.77 (1.615) 7.89 (1.210) 7.99 (1.005) 0.24 .784
IMT, mm 0.67 (0.128) 0.68 (0.118) 0.68 (0.131) 0.66 (0.142) 0.32 .724
Anthropometric profile
Body weight, kg 72.4 (10.55) 72.3 (9.94) 70.8 (10.25) 74.2 (11.86) 0.77 .467
Body mass index, kg/m2 28.5 (0.36) 28.5 (0.54) 27.9 (0.58) 29.1 (0.79) 0.79 .456
Lean body mass, kg 46.0 (4.76) 46.0 (4.69) 45.5 (5.11) 46.4 (4.63) 0.25 .776
Cardiometabolic profile
Waist circumference, cm 94.8 (7.80) 94.4 (7.00) 93.8 (7.25) 96.4 (9.46) 0.93 .397
Systolic BP, mmHg 116.5 (13.08) 116.6 (12.97) 117.4 (10.38) 115.6 (15.78) 0.15 .859
Total cholesterol, mg/dL 212.1 (39.74) 214.8 (37.51) 204.5 (45.99) 215.2 (36.81) 0.75 .476
LDL-cholesterol, mg/dL 129.1 (36.39) 130.3 (32.46) 120.2 (42.98) 135.9 (34.75) 1.47 .235
HDL-cholesterol, mg/dL 53.1 (12.61) 53.0 (12.59) 51.6 (15.14) 54.6 (9.78) 0.44 .642
Triglycerides, mg/dL 131.2 (98.40, 73.50) 147.1 (97.10, 205.65) 136.5 (105.05, 177.15) 122.3 (96.13, 146.93) 2.16 .120
Fasting glucose, mg/dL 89.6 (14.45) 90.1 (16.72) 93.6 (14.50) 84.9 (8.05) 2.89 .060
Dietary intakea
Total energy (kcal/day) 1538.2 (446.01) 1498.9 (441.99) 1552.3 (360.01) 1585.8 (525.19) 0.33 .717
Carbohydrates (g/day) 218.5 (64.91) 217.5 (74.77) 216.8 (40.41) 221.6 (68.26) 0.05 .956
Protein (g/day) 65.4 (25.62) 61.9 (18.10) 66.6 (23.40) 69.6 (35.68) 0.82 .445
Lipid (g/day) 45.6 (18.23) 43.3 (17.53) 46.4 (15.78) 48.4 (21.27) 0.68 .508
Cardiorespiratory fitness
VO2max, mL/kg/min 31.1 (6.24) 31.3 (5.80) 30.6 (6.16) 31.3 (7.15) 0.16 .849
BP = blood pressure; FMD = flow mediated dilation; HDL = high-density lipoprotein; LDL = low-density lipoprotein; PWV = pulse wave velocity; IMT = intima media
thickness; SD = standard deviation; VO2max = maximal oxygen consumption; Obesity-related conditions include hypertension and dyslipidemia.
*P-values from one-way ANOVA, chi-square or Fisher’s exact test as appropriate aAnalyzed with the sample size (N = 96).
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Table 2 Differential effects of exercise mode on markers of subclinical atherosclerosis and anthropometric and
cardiometabolic profiles over time
Modified intention-to-treat analysis (N = 92) Per-protocol analysis (N = 49)
Mean (SD)
Pa
Mean (SD)
PaAerobic
(n = 39)
Resistance
(n = 26)
Combination
(n = 27)
Aerobic
(n = 20)
Resistance
(n = 14)
Combination
(n = 15)
FMD (%) .792 .847
3 M 11.28 (3.50) 10.32 (3.80) 11.02 (3.49) 11.51 (4.02) 10.75 (3.67) 11.32 (3.37)
6 M 11.55 (3.80) 11.22 (4.43) 11.10 (3.40) 12.38 (4.43) 11.02 (4.39) 11.46 (3.74)
9 M 11.08 (4.05) 10.89 (4.33) 12.41 (4.27) 11.34 (4.88) 10.05 (4.11) 13.18 (4.34)
12 M 10.70 (3.75) 11.54 (4.99) 11.30 (4.04) 10.56 (4.15) 11.26 (5.49) 11.20 (4.09)
PWV (m/sec) .585 .732
3 M 7.91 (1.18) 7.62 (1.16) 8.11 (1.05) 7.51 (0.77) 7.49 (0.82) 7.81 (1.04)
6 M 7.83 (1.31) 7.52 (1.15) 7.76 (1.04) 7.36 (0.94) 7.34 (0.75) 7.37 (0.98)
9 M 7.94 (1.32) 7.70 (1.18) 7.96 (1.01) 7.53 (1.15) 7.60 (0.83) 7.59 (1.02)
12 M 7.88 (1.30) 7.74 (1.17) 7.96 (0.89) 7.45 (1.00) 7.67 (0.81) 7.61 (0.80)
IMT (mm) .574 .379
3 M 0.71 (0.19) 0.72 (0.17) 0.66 (0.10) 0.74 (0.24) 0.72 (0.19) 0.65 (0.09)
6 M 0.68 (0.15) 0.67 (0.14) 0.64 (0.12) 0.71 (0.18) 0.65 (0.14) 0.65 (0.13)
9 M 0.69 (0.14) 0.69 (0.14) 0.67 (0.10) 0.73 (0.16) 0.69 (0.13) 0.67 (0.10)
12 M 0.70 (0.14) 0.70 (0.13) 0.67 (0.11) 0.73 (0.15) 0.71 (0.11) 0.68 (0.12)
Body weight (kg) .539 .894
3 M 71.11 (10.69) 67.20 (9.36) 72.62 (12.06) 69.48 (11.63) 64.19 (5.59) 69.06 (8.69)
6 M 69.48 (11.70) 65.70 (9.45) 71.30 (12.25) 67.14 (12.84) 62.71 (6.27) 66.93 (7.74)
9 M 69.31 (11.81) 65.60 (9.29) 71.69 (12.25) 65.25 (8.75) 62.64 (6.26) 67.15 (7.87)
12 M 69.34 (11.84) 65.79 (9.34) 71.75 (12.63) 67.23 (12.70) 62.99 (6.57) 67.25 (8.98)
Lean body mass (kg) .717 .637
3 M 45.41 (4.96) 44.44 (5.09) 45.94 (4.95) 44.49 (5.88) 43.50 (4.92) 44.60 (3.81)
6 M 45.06 (5.28) 44.46 (4.90) 45.90 (4.83) 44.95 (6.34) 43.62 (4.69) 44.38 (3.53)
9 M 45.03 (5.18) 44.30 (5.02) 45.90 (4.62) 44.25 (4.62) 43.62 (5.05) 44.36 (3.24)
12 M 44.94 (5.14) 44.29 (4.73) 45.74 (4.76) 44.91 (6.04) 43.61 (4.48) 44.07 (3.45)
WC (cm) .790 .825
3 M 93.44 (8.06) 90.14 (8.04) 94.42 (11.36) 91.32 (8.00) 87.26 (4.72) 90.41 (7.11)
6 M 91.39 (9.41) 87.87 (8.56) 92.83 (12.00) 88.59 (9.67) 84.54 (5.25) 87.46 (7.38)
9 M 90.77 (9.82) 88.12 (8.11) 93.61 (11.68) 87.61 (8.99) 85.21 (4.68) 88.39 (6.99)
12 M 91.27 (9.33) 88.78 (7.98) 94.09 (11.58) 89.18 (9.24) 86.44 (4.97) 89.28 (7.33)
Systolic BP (mmHg) .935 .838
3 M 115.36 (15.84) 113.10 (11.99) 113.94 (17.98) 114.18 (12.81) 109.07 (9.46) 110.43 (13.70)
6 M 113.06 (15.46) 112.37 (10.23) 112.74 (17.79) 111.03 (14.66) 111.29 (12.10) 107.53 (11.93)
9 M 114.62 (14.55) 113.21 (9.53) 112.48 (17.42) 113.33 (13.19) 110.79 (8.74) 106.60 (8.01)
12 M 113.95 (14.41) 111.94 (10.29) 112.91 (18.64) 112.03 (12.17) 108.43 (9.49) 107.37 (12.45)
TC (mg/dL) .517 .689
3 M 197.11 1(44.28) 192.13 (32.70) 201.30 (34.03) 205.07 (51.68) 185.94 (28.42) 191.34 (38.60)
6 M 195.14 (36.26) 192.95 (35.23) 202.67 (38.54) 198.05 (39.55) 186.59 (28.53) 190.07 (42.89)
9 M 201.65 (37.10) 202.18 (40.98) 207.30 (38.77) 205.51 (40.42) 203.40 (41.73) 195.81 (43.64)
12 M 198.86 (42.22) 197.64 (41.46) 201.83 (40.73) 202.53 (50.23) 193.34 (42.04) 185.39 (43.74)
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Table 2 Differential effects of exercise mode on markers of subclinical atherosclerosis and anthropometric and
cardiometabolic profiles over time (Continued)
LDL-C (mg/dL) .458 .300
3 M 119.22 (38.47) 114.40 (29.22) 121.88 (36.97) 128.36 (47.15) 111.60 (31.37) 110.59 (40.99)
6 M 116.65 (30.49) 115.46 (28.85) 124.18 (35.65) 121.73 (35.34) 110.64 (27.77) 112.96 (38.75)
9 M 121.99 (32.78) 118.19 (39.83) 129.31 (39.32) 127.99 (37.16) 117.66 (46.93) 117.65 (42.97)
12 M 116.85 (36.74) 116.70 (39.86) 123.48 (39.58) 123.66 (44.04) 113.70 (46.65) 106.80 (39.76)
HDL-C (mg/dL) .973 .562
3 M 52.91 (12.29) 49.25 (12.57) 53.58 (10.09) 52.27 (12.55) 46.98 (13.77) 54.99 (11.10)
6 M 53.74 (13.04) 53.60 q(13.93) 54.79 (10.69) 53.70 (14.45) 51.99 (16.37) 56.19 (12.54)
9 M 54.52 (12.48) 55.68 (14.20) 56.20 (10.07) 55.78 (13.15) 56.04 (16.64) 59.19 (11.69)
12 M 57.72 (15.15) 54.69 (13.17) 56.39 (10.35) 59.09 (14.98) 53.51 (14.94) 59.39 (11.96)
Triglycerides (mg/dL) .784
3 M 124.90 (59.18) 142.40 (75.42) 129.23 (100.99) 122.18 (43.31) 136.77 (96.43) 128.83 (128.67)
6 M 123.74 (71.06) 119.47 (57.73) 118.53 (56.25) 113.06 (57.94) 119.85 (69.02) 104.58 (58.74)
9 M 125.72 (68.76) 141.51 (91.41) 108.93 (50.78) 108.70 (44.08) 148.51 (120.31) 94.87 (52.08)
12 M 120.88 (70.84) 131.24 (82.54) 109.78 (48.56) 97.81 (38.99) 130.63 (107.88) 96.03 (48.36)
Fasting glucose (mg/dL) .413 .034
3 M 88.93 (9.87) 94.54 (19.83) 89.39 (7.69) 86.40 (7.51) 93.54 (12.40) 88.52 (7.78)
6 M 85.80 (7.90) 91.68 (19.82) 85.67 (7.47) 83.85 (6.56) 89.71 1(12.61) 82.56 (7.86)
9 M 84.98 (9.76) 93.16 (22.15) 84.97 (8.23) 82.33 (9.23) 94.61 (17.40) 81.33 (8.53)
12 M 89.78 (8.28) 92.84 (22.41) 86.30 (7.22) 89.26 (7.07) 93.54 (18.33) 81.91 (5.95)*
VO2max (mL/kg/min)
3 M 31.77 (5.45) 32.55 (5.04) 32.02 (5.41) .972 32.72 (3.92) 33.75 (4.57) 33.45 (4.91) .052
6 M 35.05 (6.72) 34.32 (5.50) 36.36 (6.90) 36.37 (4.77) 35.59 (3.42) 39.27 (4.87)
9 M 35.62 (6.81) 35.07 (5.89) 34.49 (5.95) 38.24 (5.48) 36.25 (5.14) 36.31 (4.17)
12 M 34.11 (6.29) 34.61 (6.05) 34.89 (6.45) 35.41 (4.84) 35.82 (5.67) 37.04 (5.28)
aP-values for significance of interaction effects between exercise group and time via the generalized estimating equation.
FMD = flow mediated dilation; PWV = pulse wave velocity; HDL-C = high-density lipoprotein cholesterol; IMT = intima media thickness; LDL-C = low-density lipoprotein
cholesterol; SD = standard deviation; TC = total cholesterol; VO2max =maximal oxygen consumption; WC =waist circumference.
*P < .05 is for a significant difference in fasting glucose levels by exercise mode at 12 months.
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lean body mass (p = .040), waist circumference (p < .001),
total cholesterol (p = .006), LDL cholesterol (p = .020), and
HDL cholesterol levels (p < .001), fasting glucose levels
(p < .001), and VO2max (p < .001), based on the modified
ITT analysis results. In other words, regardless of the
exercise modes, PWV, IMT, body weight, waist circumfer-
ence, and total and LDL cholesterol levels significantly
decreased over time in the diet-plus-exercise intervention;
HDL cholesterol level and VO2max significantly increased
over time in the diet-plus-exercise intervention. Specific-
ally, changes in body weight, waist circumference, HDL
cholesterol level, and VO2max primarily showed linear
trends. The IMT and fasting glucose levels showed
quadratic curve trends, while PWV and total and LDL
cholesterol levels showed cubic curve trends, based on
the modified ITT analysis results. The findings fromthe PP analyses almost closely matched those from the
modified ITT analyses.
Discussion
The exercise mode did not have significant differential
effects on FMD, PWV, and IMT in the diet-plus-exercise
intervention of a 12-month weight management program.
However, the exercise mode had a significant differential
effect on fasting glucose levels; combination exercise
lowered fasting glucose levels more effectively than
aerobic exercise. Meanwhile, there were significant time
effects of the diet-plus-exercise intervention, i.e., reduc-
tions in PWV and IMT in cubic and quadratic trends,
respectively, and improvements in body weight; waist
circumference; levels of total, LDL, and HDL cholesterol;
and cardiorespiratory fitness in linear, quadratic, or cubic
trends.
Table 3 Time effects on markers of subclinical atherosclerosis and anthropometric and cardiometabolic profiles
Modified intention-to-teat analysis (N = 92) Per-protocol analysis (N = 49)
Mean (SD) Pa Mean (SD) Pa
FMD (mm)
3 M 10.93 (3.57) .676 11.23 (3.67) .628
6 M 11.33 (3.84) 1171 (4.17)
9 M 11.41 (4.20) 11.54 (4.57)
12 M 11.11 (4.18) 10.93 (4.47)
PWV (m/sec)
3 M 7.89 (1.14) .048‡ 7.60 (0.87) .055
6 M 7.72 (1.19) 7.36 (0.88)
9 M 7.88 (1.19) 7.57 (1.00)
12 M 7.87 (1.15) 7.56 (0.88)
IMT (mm)
3 M 0.70 (0.16) .018†‡ 0.71 (0.19) .042
6 M 0.67 (0.14) 0.67 (0.16)
9 M 0.68 (0.13) 0.70 (0.13)
12 M 0.69 (0.13) 0.71 (0.13)
Body weight (kg)
3 M 70.45 (10.86) <.001*†‡ 67.84 (9.46) <.001*†‡
6 M 68.95 (11.37) 65.81 (9.87)
9 M 68.96 (11.41) 65.08 (7.84)
12 M 69.04 (11.55) 66.03 (10.14)
Lean body mass (kg)
3 M 45.29 (4.97) .040* 44.65 (5.01) .153
6 M 45.14 (5.02) 44.40 (5.08)
9 M 45.08 (4.96) 44.10 (4.29)
12 M 44.99 (4.89) 44.28 (4.86)
WC (cm)
3 M 92.80 ( 9.21) <.001*†‡ 89.88 (7.01) <.001†
6 M 90.82 (10.10) 87.09 (7.95)
9 M 90.85 (10.08) 87.14 (7.26)
12 M 91.39 ( 9.81) 88.42 (7.60)
Systolic BP(mmHg)
3 M 114.30 (15.41) .245 111.57 (12.21) .253
6 M 112.77 (14.80) 110.03 (13.00)
9 M 113.59 (14.18) 110.43 (10.65)
12 M 113.08 (14.69) 109.57 (11.51)
TC (mg/dL)
3 M 196.93 (38.15) .006‡ 195.40 (42.20) .013‡
6 M 196.73 (36.47) 192.33 (37.43)
9 M 203.46 (38.37) 201.86 (41.14)
12 M 199.39 (41.15) 194.66 (45.70)
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Table 3 Time effects on markers of subclinical atherosclerosis and anthropometric and cardiometabolic profiles (Continued)
LDL-C (mg/dL)
3 M 118.64 (35.38) .020‡ 118.13 (41.36) .034‡
6 M 118.52 (31.52) 115.88 (34.15)
9 M 123.07 (36.68) 121.74 (41.40)
12 M 118.76 (38.17) 115.65 (43.25)
HDL-C (mg/dL)
3 M 52.07 (11.78) <.001* 51.59 (12.63) <.001*
6 M 54.01 (12.54) 53.97 (14.28)
9 M 55.34 (12.25) 56.92 (13.64)
12 M 56.47 (13.26) 57.59 (14.06)
Triglycerides (mg/dL)
3 M 131.12 (77.41) .289 128.39 (90.15) .197
6 M 121.00 (62.72) 112.40 (60.51)
9 M 125.25 (71.84) 115.99 (77.68)
12 M 120.55 (68.62) 106.64 (68.35)
Fasting glucose (mg/dL)
3 M 90.65 (13.13) <.001† 89.09 (9.52) .034*†
6 M 87.42 (12.54) 85.13 (9.33)
9 M 87.29 (14.41) 85.60 (13.13)
12 M 89.62 (13.70) 88.23 (11.93)
VO2max (mL/kg/min)
3 M 32.06 (5.27) <.001*†‡ 33.23 (4.34) <.001*†
6 M 35.24 (6.44) 37.04 (4.63)
9 M 35.14 (6.26) 37.05 (4.97)
12 M 34.48 (6.21) 36.02 (5.15)
aP-values for an equality of mean values across periods; Significance of trend tests: *Linear trend, †Quadratic trend, ‡Cubic trend.
FMD = flow mediated dilation; PWV = pulse wave velocity; IMT = intima media thickness; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density
lipoprotein cholesterol; SD = standard deviation; TC = total cholesterol; VO2max = maximal oxygen consumption; WC = waist circumference.
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nor time effects of the diet-plus-exercise intervention on
FMD in women with abdominal obesity. Several studies
have previously reported the beneficial effects of both
aerobic and resistance exercise on FMD. Aerobic exercise
training is well known to improve FMD [30-32], although
only a few studies have reported the effects of aerobic
exercise on FMD in obese individuals. Watts et al. [33]
reported that FMD was significantly greater among
trained obese children compared with untrained obese
children after 8 weeks of aerobic exercise training [33].
Similarly, either resistance or combination exercise train-
ing may be effective in improving endothelial function,
although this was found in small-scale studies, thereby
necessitating further confirmation [13,34,35]. In a study of
30 overweight women, Olson et al. [13] reported that
FMD improved significantly in a resistance exercise group
compared with a control group after a 1-year resistance
training intervention [13]. Maiorana et al. [35] reported in
a crossover study that a combination of aerobic andresistance exercise for 8 weeks significantly increased
FMD among 16 patients with type 2 diabetes mellitus
[35]. Nevertheless, only a few studies have reported the
differential effects of exercise mode [36]. Kwon et al.
[36] found that aerobic exercise provide greater im-
provement in FMD than resistance exercise among 40
overweight women with type 2 diabetes mellitus in a
comparison study of exercise mode [36].
In the present study, the non-significant differential
effects of exercise mode on FMD for women with abdom-
inal obesity may be explained by the complex effects of
both exercise and diet in our study design. In previous
studies, the effects of exercise training combined with
dietary interventions have thus far yielded mixed results
among obese individuals. Hamdy et al. [37] reported an
improvement in the FMD in 24 obese individuals after
a 6-month lifestyle modification consisting of both
energy-restricted diet and aerobic exercise training [37].
In contrast, Wycherley et al. [19] did not find any signifi-
cant improvement in the FMD in 29 obese patients with
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aerobic exercise training [19]. Such conflicting findings
might be attributable to distinct characteristics of FMD
from other measures of subclinical atherosclerosis such as
carotid IMT. The Firefighters and their Endothelium
study (2005) [38] showed that the FMD had no significant
correlation with carotid IMT among middle-aged men
who were at low-to-moderate risk of cardiovascular
diseases [38]. FMD is a well-standardized measure of
endothelial function that is considered an early mani-
festation of atherosclerosis [39]. Furthermore, FMD is
an acute indicator of vascular function, as opposed to
carotid IMT, which is a chronic indicator of vascular
structural abnormalities. Therefore, changes in FMD may,
in part, result from acute influences such as within-
individual variations in the exposure to the complex
effects of either exercise or diet (i.e., changes in body
weight or cardiometabolic risk factors) when they were
measured. Meanwhile, non-significant changes in the
FMD found in the present study may also be explained
by the normal range (≥5.5%) of the FMD values at base-
line (10.8%; range, 4.0–18.0% in our data). Swift et al.
[31] reported a significant improvement in the FMD in
obese women with impaired FMD, but not in those
with normal FMD at baseline after a 6-month aerobic
exercise training program [31].
We found no differential effect of exercise mode on
aortic PWV, but a significant reduction in aortic PWV
with the diet-plus-exercise intervention over time. Aerobic
exercise training has previously been reported to decrease
aortic PWV in a few studies, although the findings were
limited to healthy men. Hayashi et al. [40] reported that
16 weeks of aerobic training with moderate-intensity
walking and jogging significantly decreased aortic PWV in
17 sedentary middle-aged men [40]. Collier et al. [41]
found that aerobic exercise led to a decrease in aortic
PWV, whereas resistance exercise led to a significant
increase in aortic PWV after 4-week training among 30
middle-aged individuals with prehypertension or stage1
hypertension [41]. However, such increases in aortic PWV
with resistance training need to be further clarified. In
fact, we did not find any increase in aortic PWV in the
resistance exercise group. Similarly, a meta-analysis by
Miyachi showed that resistance training may not be
associated with increases in aortic PWV in middle-aged
subjects [42]. Meanwhile, our data showed that the reduc-
tion in aortic PWV peaked at 6 months in the entire
intervention and rebounded after the next 6 months in
the diet-plus-exercise intervention in a cubic curve
trend; this trend appeared to parallel with the weight
loss trend in our data. Dengo et al. [43] reported that a
reduction in aortic PWV correlated with reductions in
total body and abdominal adiposity among overweight
and obese adults [43]. In this context, the reduction ofaortic PWV may be primarily related to exercise-induced
energy expenditure contributing to weight loss rather than
exercise mode.
We did not find any differential effect of exercise modes
on carotid IMT. Instead, we found a significant regression
in carotid IMT with the diet-plus-exercise intervention as
a time effect. Similarly, Spence et al. [44] reported that
there was no significant differential effect of aerobic
versus resistance exercise training on carotid IMT, but
there was a significant time effect among 23 young
healthy male subjects with 24 weeks of exercise training
[44]. Dutheil et al. [17] investigated the effects of combin-
ation exercise on carotid IMT according to exercise inten-
sity, and reported that moderate-resistance high-aerobic
exercise was more effective for the regression of carotid
IMT than moderate-resistance moderate-aerobic exercise
[17]. Thus, we speculate that the effects of exercise train-
ing on carotid IMT may be influenced by exercise inten-
sity but not by exercise mode.
In our findings, the regression effect of exercise training
on carotid IMT (i.e., a time effect) was not linear over
time, with a peak at 6 months that was not maintained
to 12 months, consistent with the findings of a previous
study [45]. There was little evidence for beneficial effects of
a lifestyle intervention (i.e., either diet-alone or diet-plus-
exercise intervention) on carotid IMT among overweight
and obese individuals [45-47]. Fuentes et al. [45] reported
a significant regression in carotid IMT over a 24-month
follow-up with a diet-induced weight-loss intervention
involving 60 obese individuals [45]. Carotid IMT is a
vascular measure of structural changes in the carotid
arteries, so a reduction in carotid IMT may require long-
duration interventions. Thus, the underlying mechanism
of these short-term changes in carotid IMT with the
diet-plus-exercise intervention need to be further clarified,
but we could speculate that the changes are the result
of various favorable changes in the cardiometabolic risk
factors that occur concomitantly with weight loss induced
by the diet-plus-exercise intervention.
Finally, we found a significant differential effect of
exercise mode on fasting glucose levels but not on
vascular measures (i.e., FMD, PWV, and IMT); specif-
ically, combination of aerobic and resistance exercises
was significantly more effective in lowering fasting glucose
levels than aerobic exercise alone in the diet-plus-exercise
intervention. The beneficial effect of a combination of
aerobic and resistance exercises on glucose control has
been previously reported only in patients with type 2
diabetes [21,48,49] but not in overweight and obese
individuals. Snowling et al. [49] concluded, from their
meta-analysis, that aerobic, resistance, and combination
exercises had small-to-moderate beneficial effects on glu-
cose control in patients with type 2 diabetes; particularly,
compared to aerobic exercise, combination exercise was
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extent [49]. Meanwhile, the conflicting effects of exercise
mode on fasting glucose levels versus vascular measures
may be explained by different exercise-induced physio-
logical responses. The beneficial effect of combination
exercise on fasting glucose levels may be attributable to
an additional beneficial effect of resistance exercise to
aerobic exercise. Physiologically, similar to aerobic exercise,
resistance exercise can increase glucose uptake and glyco-
gen repletion in skeletal muscle following exercise by
promoting contraction-mediated GLUT4 translocation
with increased activation of AMP-activated protein kinase
[50]. In this context, both aerobic and resistance exercise
may provide a synergistic effect on glucose metabolism.
In contrast, non-significant differential effects of exercise
mode on vascular measures (i.e., PWV and IMT) may
indicate that changes in vascular measures influenced
by vascular tone and remodeling with exercise training
are not influenced by exercise mode but instead by
other components such as exercise intensity or exercise
expenditure [17].
This study, to the best of our knowledge, is the first to
report on the effects of exercise modes in a weight man-
agement intervention on major markers of subclinical
atherosclerosis such as endothelial dysfunction, arterial
stiffness, and carotid IMT. Nevertheless, this study has
several limitations. First, the attrition rate in the study
was 55% over 12 months, and this may have led to a bias
influencing the validity of results. However, the present
study was initiated and implemented as a community-
based program and its attrition rate was similar to that
in previous studies conducted as community-based pro-
grams [51]. Second, of the participants included in the
modified ITT analysis (n = 92), 68% had a menstrual cycle.
FMD may modulate in response to changing hormonal
patterns during the menstrual cycle [52]. Lack of consider-
ation of the effects of the menstrual cycle in vascular
measurements might have underestimated or overesti-
mated changes in FMD. Third, since all the participants
in present study were Korean women, the results cannot
be generalized to men or other ethnic groups.
Conclusions
For women with abdominal obesity, a combination of
aerobic and resistance exercise may be preferable to a
single mode (i.e., aerobic or resistance exercise) for
effective glucose control. Regardless of exercise mode,
exercise interventions combined with dietary interven-
tions may be beneficial for reducing the risk of subclinical
atherosclerosis and cardiometabolic risk in women with
abdominal obesity. Such beneficial effects of exercise
training may not be differentiated by exercise mode but
by other exercise components such as exercise intensity
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